Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

Condition(s) studied

Investigational drug(s) / intervention(s)

annual follow-up during 10 years: an annual follow-up is carried out systematically for a total of 10 years in order to detect the subsequent occurrence of CKD

Study summary

Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia.

Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense.

The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood.

Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.

Eligibility

Primary outcome measure(s)

• prevalence of the Chronic Kidney Disease (CKD) — until 10 years
  prevalence of the CKD is measured by the the rate of new CKD Diagnoses (according to the standard definitions)

Trial sites (2)

More Centre Hospitalier le Mans trials in France

Other trials for the same condition